Pharmaceuticals News and Research

RSS

Climbing cost of decades-old drugs threatens to break Medicaid bank

Skyrocketing price tags for new drugs to treat rare diseases have stoked outrage nationwide. But hundreds of old, commonly used drugs cost the Medicaid program billions of extra dollars in 2016 vs. 2015, a Kaiser Health News data analysis shows.

14 Aug 2017

FDA warns against use of many drugs, dietary supplements due to potential contamination

The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due to potential contamination with the bacteria Burkholderia cepacia (B. cepacia) and the risk for severe patient infection.

11 Aug 2017

Small clinical trial shows promise for treating rare neurodegenerative disease

Results of a small clinical trial show promise for treating a rare neurodegenerative condition that typically kills those afflicted before they reach age 20.

11 Aug 2017

New technique combines electricity and chemistry to scale up drug manufacturing

Give your medicine a jolt. By using - electrochemistry - a technique that combines electricity and chemistry, future pharmaceuticals - including many of the top prescribed medications in the United States - soon may be easily scaled up to be manufactured in a more sustainable way.

10 Aug 2017

Study shows sustained impact and effectiveness of rotavirus vaccine program

Following the introduction of routine childhood vaccination against rotavirus, a common cause of diarrheal illness, more than 380,000 children avoided hospitalization for diarrhea from 2008 to 2013 in the U.S., thus saving an estimated $1.2 billion in direct medical costs.

10 Aug 2017

Pharmaceutical companies may have strong hold on how doctors prescribe opioids, study suggests

One in twelve physicians - and nearly one in five family medicine physicians - accepted payments from pharmaceutical companies related to opioids, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine.

10 Aug 2017

Senate Democrats delay HHS nominee over women’s health funding

Last week, 65 administration nominees — including four to Health and Human Services — sailed through the Senate confirmation process by unanimous vote without any debate. One candidate left out was Dr. Brett Giroir, a Texas physician, who is the president's choice for assistant secretary of health.

10 Aug 2017

Researchers investigate genetic mutations in sperm cells to help prevent birth defects

It's about preventing birth defects. Associate pharmaceutical sciences professor Wenfeng An and his team at South Dakota State University are investigating mobile DNA segments, known as L1s, in sperm cells with the goal to treat families at risk for genetic mutations before they conceive.

10 Aug 2017

Hospitals slashed use of two heart drugs after huge price hikes

Even before media reports and a congressional hearing vilified Valeant Pharmaceuticals International for raising prices on a pair of lifesaving heart drugs, Dr. Umesh Khot knew something was very wrong.

9 Aug 2017

Researchers awarded $1.5 million each to help uncover breakthrough in heart-health research

Two researchers have been awarded grants that could help uncover the next breakthrough in heart-health research, the American Heart Association and The Paul G. Allen Frontiers Group announced Wednesday.

9 Aug 2017

ASU Biodesign researchers develop more potent, safer plant-based Zika vaccine

The worldwide Zika threat first emerged in 2015, infecting millions as it swept across the Americas. It struck great fear in pregnant women, as babies born with severe brain birth defects quickly overburdened hospitals and public health care systems.

9 Aug 2017

Researchers translate neuroimaging tools to study renal fibrosis in diabetic rats

Osaka University researchers, in collaboration with several Japanese companies, translate neuroimaging tools to study renal fibrosis in rat kidney.

9 Aug 2017

Cryo-electron microscopy advances by Thermo Fisher Scientific drives structural biology research

Thermo Fisher Scientific, the world leader in serving science, has extended its leadership in cryo-electron microscopy (cryo-EM) with the introduction of two new instruments: the Thermo Scientific Krios G3i and the Thermo Scientific Glacios cryo-transmission electron microscopes (cryo-TEMs).

From Thermo Fisher Scientific Inc. 9 Aug 2017

Scientists stop formation of protein clumps linked to ALS and frontotemporal dementia

Scientists report in a new study that by imitating a natural process of cells, they prevented the formation of protein clumps associated with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.

8 Aug 2017

New way of screening compounds may help speed up drug development

Scientists have created a new way of screening compounds that is more sensitive than existing methods, opening up the possibility of finding new drugs for many diseases.

7 Aug 2017

Hitgen and LEO Pharma collaborate to discover small molecule leads for multiple therapeutic targets

HitGen Ltd announced that the company has entered into a multi-target multi-year collaboration with LEO Pharma A/S, to discover novel small molecule leads for multiple therapeutic targets of interest to LEO Pharma.

7 Aug 2017

UNC-Chapel Hill receives $1.6 million grant to help African-American patients with glaucoma

The University of North Carolina at Chapel Hill has received a grant worth nearly $1.6 million over four years from the Agency for Healthcare Research and Quality to help reduce vision problems in African-Americans caused by glaucoma.

4 Aug 2017

PerkinElmer introduces affordable clinical genomics services

PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced the launch of PerkinElmer Genetics' clinical genomics services.

3 Aug 2017

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

The U.S. Food and Drug Administration (FDA) yesterday approved Vyxeos - a fixed dose combination chemotherapy for the treatment of adults with two types of acute myeloid leukemia (AML). The types of AML that would be treated with Vyxeos include newly diagnosed therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of the chemotherapy drugs daunorubicin and cytarabine.

3 Aug 2017

Vascularized 3D bioprinted liver tissue offers more accurate system for drug toxicity testing

Artificially constructed human tissues and organs have been developed with a number of different purposes in mind, from advanced robotics and novel materials to drug screening.

3 Aug 2017

Pharmaceuticals News and Research

Climbing cost of decades-old drugs threatens to break Medicaid bank

FDA warns against use of many drugs, dietary supplements due to potential contamination

Small clinical trial shows promise for treating rare neurodegenerative disease

New technique combines electricity and chemistry to scale up drug manufacturing

Study shows sustained impact and effectiveness of rotavirus vaccine program

Pharmaceutical companies may have strong hold on how doctors prescribe opioids, study suggests

Senate Democrats delay HHS nominee over women’s health funding

Researchers investigate genetic mutations in sperm cells to help prevent birth defects

Hospitals slashed use of two heart drugs after huge price hikes

Researchers awarded $1.5 million each to help uncover breakthrough in heart-health research

ASU Biodesign researchers develop more potent, safer plant-based Zika vaccine

Researchers translate neuroimaging tools to study renal fibrosis in diabetic rats

Cryo-electron microscopy advances by Thermo Fisher Scientific drives structural biology research

Scientists stop formation of protein clumps linked to ALS and frontotemporal dementia

New way of screening compounds may help speed up drug development

Hitgen and LEO Pharma collaborate to discover small molecule leads for multiple therapeutic targets

UNC-Chapel Hill receives $1.6 million grant to help African-American patients with glaucoma

PerkinElmer introduces affordable clinical genomics services

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

Vascularized 3D bioprinted liver tissue offers more accurate system for drug toxicity testing

Event guide: World ADC Asia eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring